Invitrogen™ IL-1 beta Mouse ELISA Kit

Ref.: BL-RE-171993Manufacturer ref.: BMS6002-2TEN 10 x 96 Tests
€3,840.00 excl. VAT

Interleukin-1 beta (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive pro-form that accumulates in the cytosol.…

Accession number
P10749
Dose range
7.8 to 500
Sensitivity of the dosage
1.2 pg/mL
Conjugate
HRP
Product type
ELISA
Brand
Invitrogen

Interleukin-1 beta (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive pro-form that accumulates in the cytosol.…

Interleukin-1 beta (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive pro-form that accumulates in the cytosol. Cleavage of pro-IL-1 beta into the active 17 kDa protein requires the activation of inflammasomes, which are multi-protein complexes that respond to pathogens, stress conditions, and other danger signals. Inflammasome activation triggers the processing of the caspase-1 precursor into its active form, which in turn cleaves pro-IL-1 beta. IL-1 beta lacks a signal sequence peptide for classical ER/Golgi pathway and is secreted alongside caspase-1 via an alternate and incompletely understood mechanism. Although IL-1 beta is most often secreted in its active form, secretion of the uncleaved protein may be detectable under some biological conditions. IL-1 beta signals through two receptors, IL-1RI and IL-1RII, both of which are shared with IL-1 alpha. IL-1 beta activity can be moderated by IL-1 Receptor Antagonist (IL-1RA), a protein produced by many cell types that blocks receptor binding through competitive inhibition. IL-1 beta play an important role in innate host defense by triggering the production of other proinflammatory cytokines in target cells and initiating acute-phase responses to infection and injury. Elevated levels of IL-1 beta have been associated with many chronic inflammatory conditions IL-1 beta neutralizing antibodies potential therapeutic value.

Sensitivity

Sensitivity of the dosage: 1.2 pg/mL.

Measurement range

Dose range: 7.8 to 500.

Duration of dosing

Total duration of dosing: 3 h 10 min.

Reproducibility

Coefficient of variation in intra-dose 5.1%, inter-dose 5.7%.

Samples

Sample type: Serum (volume 50 µL).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)18031673
Specifications
Accession numberP10749
Dose range7.8 to 500
Sensitivity of the dosage1.2 pg/mL
ConjugateHRP
Product typeELISA
Type of sampleSerum
For use with (equipment)Colorimetric Microplate Reader
Genetic identification (Enter)16176
Gene symbol(s)IL1B
Coefficient of inter-dose variation5.7%
Coefficient of intra-dose variation5.1%
Contents of kitsPre-coated 96 well flat, Standard, Sample Dilute, Assay Buffer Concentrate, Biotinylated Detection Antibody, SAV-HRP, Wash Buffer, Chromogen, Stop Solution, Adhesive Plate Covers
Marker or dyeHRP
Quantity10 x 96 Tests
Regulatory statusRUO
TargetMouse
Test time1 hr 20 min
Physical characteristics
Volume of sample50 µL
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing3 hr 10 min

Origin and customs

Manufacturer ref.BMS6002-2TEN
Country of originAutriche
HS customs code3822 11 00 00
A question or a specific configuration?
Contact us for a quote.